ABSCI CORP. news, videos and press releases
For more news please use our advanced search feature.
ABSCI CORP. - More news...
ABSCI CORP. - More news...
- Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
- Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
- Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
- Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Absci Announces Pricing of Public Offering of Common Stock
- Absci Announces Proposed Public Offering of Common Stock
- Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
- Absci to Participate in Upcoming Investor Conferences
- Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
- Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
- Absci to Participate in the 26th Annual Needham Growth Conference
- Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
- Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
- Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
- Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
- Absci to Participate in Upcoming Investor Conferences
- Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
- Absci to Host R&D Day on October 4, 2023
- Absci to Participate in Upcoming Investor Conferences
- Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
- Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
- Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
- Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
- Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
- Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
- Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results